Project Details
世纪华宝生物

楚雄世纪华宝生物产业开发有限公司


合作投资项目。
占据资源优势的生物资源开发利用企业,为细分领域的龙头。

Related items
With completed Phase 1 and 2 clinical trials in non-small-cell lung cancer (NSCLC), BeyondSpring has a strong body of safety and efficacy data suggesting that a combination therapy of Plinabulin and commonly-used chemotherapy drug docetaxel can extend the overall survival of targeted late-stage NSCLC patients. Based on consultation with the U.S. FDA, BeyondSpring are conduc
深圳美思康电子有限公司 大型IVD集成系统制造商,拥有市场领先的高性价比流式集成系统技术平台。
Valley Life Sciences Institute life commitment, wisdom, angel investors, major research new rapid low-cost disposable electrochemical biosensor device immunity, the principle means has been completed and received international PCT patent. The project is expected to lead to disruptive technology revolution, it has broad commercial prospects.
融智生物科技(青岛)有限公司 中国领先的ONE STEP 基因芯片分析系统制造商。"千人计划"海归人才领衔。
More Projects
Home
About Us
News
Information
Investment
Jobs
Contact
Incubation Project
Company Profile
Philosophy
Areas of concern
Business
Entrusted investment
 
Industry News
Industry Information
Investment Advantages
Principal investment
Talent Concept
Careers
Shenzhen Sangel Venture Capital Co.,Ltd
Address:Room 2401/2402, Shenzhen Bay VC&PE Builing, Nanshan District, Shenzhen,Guangdong Province, China 
Tel:0755-26069007
Fax:0755-26491800
Website:www.sangelvc.com

Copyright © 2008-2016 | All Rights Reserved | Shenzhen Sangel Venture Capital Co.,Ltd. | ICP:15012769